Evaluation of a Novel Tc‐24 Recombinant Antigen ELISA for Serologic Detection of Trypanosoma cruzi Infection in Dogs: A Pilot Study
Veterinary Medicine and Science · 2025
DOI: 10.1002/vms3.70570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Medicine and Science, 2025. Verfasst von Rojelio Mejia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics-Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA. Hauptthemen laut MEDLINE: Chagas Disease, Dog Diseases, Trypanosoma cruzi, Antigens, Protozoan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, American Kennel Club Canine Health Foundation, NIH HHS.
Abstract (Originalsprache)
Chagas disease, caused by the protozoan Trypanosoma cruzi , is a significant challenge for canine health, with limited diagnostic tools. This study assessed the performance of a novel Tc‐24 recombinant antigen ELISA compared to three commercial diagnostic tests on 70 serum samples from kennel dogs in Texas. The Tc‐24 ELISA demonstrated high sensitivity (87.5%) and specificity (91.2%) compared to Indirect Fluorescent Antibody (IFA) testing, with significant differences in Tc‐24 optical density (OD) between positives and negatives (0.607 vs. 0.089, p < 0.001). When compared to Chagas Stat‐Pak (SP), Tc‐24 ELISA showed sensitivity and specificity values of 82.1% and 86.7%, respectively ( p < 0.001). For Chagas Detect Plus (IB), the assay achieved a sensitivity of 80.0% and specificity of 93.1% ( p < 0.001). Spearman correlation analysis revealed significant associations between Tc‐24 OD and SP ( r = 1.0, p = 0.0167), IB ( r = 0.9, p = 0.0833) and IFA ( r = 0.6273, p = 0.044). Elevated immunochromatographic values in commercial kits (SP or IB) correlated with Tc‐24 OD (1.17 vs. 0.039, p < 0.001), achieving 100% sensitivity and 95.8% specificity based on positive results from commercial kits. These findings suggest that Tc‐24 ELISA is a reliable and accurate serological tool for diagnosing T. cruzi infection in dogs, with the potential to enhance diagnostic capabilities in veterinary medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics-Tropical Medicine, Baylor College of Medicine, Houston, Texas, USA.
- Department of Veterinary Pathobiology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
- Department of Veterinary Small Animal Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.
ORCID-Profile: Rojelio Mejia, Sarah A Hamer
Förderung
- NIAID NIH HHS
- American Kennel Club Canine Health Foundation
- NIH HHS
- National Institutes of Health
Zitieren
APA
Mejia, R., Verocai, G. G., Mosley, I. A., Saunders, A. B., Zhan, B., Vongthavaravat, L., Busselman, R. E., & Hamer, S. A. (2025). Evaluation of a Novel Tc‐24 Recombinant Antigen ELISA for Serologic Detection of Trypanosoma cruzi Infection in Dogs: A Pilot Study. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.70570
Vancouver
Mejia R, Verocai GG, Mosley IA, Saunders AB, Zhan B, Vongthavaravat L, et al. Evaluation of a Novel Tc‐24 Recombinant Antigen ELISA for Serologic Detection of Trypanosoma cruzi Infection in Dogs: A Pilot Study. Veterinary Medicine and Science. 2025. doi:10.1002/vms3.70570
BibTeX
@article{Mejia2025,
author = {Mejia, Rojelio and Verocai, Guilherme G and Mosley, Ilana A and Saunders, Ashley B and Zhan, Bin and Vongthavaravat, Lindsey and Busselman, Rachel E and Hamer, Sarah A},
title = {Evaluation of a Novel Tc‐24 Recombinant Antigen ELISA for Serologic Detection of Trypanosoma cruzi Infection in Dogs: A Pilot Study},
journal = {Veterinary Medicine and Science},
year = {2025},
doi = {10.1002/vms3.70570}
}
EUVIMED